Authors: Guo Qi, Wang Yandong DOI: 10.3760/cma.j.cn115989-20210705-00394 Published 2023-07-10 Cite as Chin J Exp Ophthalmol, 2023, 41(7): 708-712. Abstract [Download PDF] [Read Full Text] Non-infectious uveitis (NIU) is a serious sight-threatening disease caused by chronic inflammation and its complications.First-line treatment of NIU […]
Tag: Adalimumab
Uveitis complicated with systemic tuberculosis associated with inappropriate adalimumab therapy: two case reports
Authors: Sun Ludan, Zhu Jie, Zhu Jun, Yu Jing, Chen Fang DOI: 10.3760/cma.j.cn115989-20220506-00196 Published 2022-08-10 Cite as Chin J Exp Ophthalmol, 2022, 40(8): 723-724. [View PDF] [Read Full Text] Contributor Information Sun Ludan Department of Ophthalmology, Northern Jiangsu People’s Hospital of Jiangsn Province, Yangzhou 225001, China Zhu Jie Department of Ophthalmology, Northern Jiangsu People’s Hospital of Jiangsn […]
Pay attention to the risk of infection and tumor progression during application of TNF-α inhibitors in uveitis
Authors: Chi Ying, Yang Liu DOI: 10.3760/cma.j.cn115989-20211020-00571 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 929-932. Abstract [View PDF] [Read Full Text] Adalimumab, one of the tumor necrosis factor-α (TNF-α) inhibitors, has been approved as a therapeutic drug for non-infectious intermediate, posterior and pan-uveitis […]